Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

The microbiome may be linked to hair loss and could be a target for new treatments.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

The mixed preparation helped hair regrowth but wasn't better than minoxidil.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.